May 4, 2020 / 5:18 AM / 25 days ago

BRIEF-Ipsen Enters Into Option Agreement With IRICoR, University of Montreal

May 4 (Reuters) - IPSEN SA:

* ENTERS INTO AN OPTION AGREEMENT WITH IRICOR AND UNIVERSITE DE MONTRÉAL FOR A DISCOVERY-STAGE ONCOLOGY PROGRAM

* IPSEN WOULD ACQUIRE AN EXCLUSIVE LICENSE FOR THE WORLDWIDE RIGHTS TO A HIGH-VALUE ONCOLOGY PROGRAM

* PROGRAM, CURRENTLY AT LEAD OPTIMIZATION STAGE, WILL FOCUS ON ADVANCING THE CURRENT LEAD MOLECULES TO THE DEVELOPMENT CANDIDATE STAGE

* FINANCIAL TERMS OF AGREEMENT, INCLUDING RESEARCH, DEVELOPMENT, COMMERCIAL MILESTONES AND ROYALTIES HAVE NOT BEEN DISCLOSED. Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below